Network Pharmacology and Molecular Docking on the Molecular Mechanism of Luo-hua-zi-zhu (LHZZ) Granule in the Prevention and Treatment of Bowel Precancerous Lesions

The Luo-hua-zi-zhu (LHZZ) granule has been widely used for the treatment of colorectal adenoma (CRA), which is a precursor of colorectal cancer (CRC). However, the active components of LUZZ and its mechanism of action against CRA have not yet been elucidated. This study was designed to investigate t...

Full description

Saved in:
Bibliographic Details
Main Authors: Cui Guo (Author), Xingdong Kang (Author), Fang Cao (Author), Jian Yang (Author), Yimin Xu (Author), Xiaoqiang Liu (Author), Yuan Li (Author), Xiumei Ma (Author), Xiaoling Fu (Author)
Format: Book
Published: Frontiers Media S.A., 2021-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_b09aec7a4a5c47e3b138d7c5b79ecf4f
042 |a dc 
100 1 0 |a Cui Guo  |e author 
700 1 0 |a Cui Guo  |e author 
700 1 0 |a Xingdong Kang  |e author 
700 1 0 |a Fang Cao  |e author 
700 1 0 |a Jian Yang  |e author 
700 1 0 |a Yimin Xu  |e author 
700 1 0 |a Xiaoqiang Liu  |e author 
700 1 0 |a Xiaoqiang Liu  |e author 
700 1 0 |a Yuan Li  |e author 
700 1 0 |a Xiumei Ma  |e author 
700 1 0 |a Xiaoling Fu  |e author 
245 0 0 |a Network Pharmacology and Molecular Docking on the Molecular Mechanism of Luo-hua-zi-zhu (LHZZ) Granule in the Prevention and Treatment of Bowel Precancerous Lesions 
260 |b Frontiers Media S.A.,   |c 2021-02-01T00:00:00Z. 
500 |a 1663-9812 
500 |a 10.3389/fphar.2021.629021 
520 |a The Luo-hua-zi-zhu (LHZZ) granule has been widely used for the treatment of colorectal adenoma (CRA), which is a precursor of colorectal cancer (CRC). However, the active components of LUZZ and its mechanism of action against CRA have not yet been elucidated. This study was designed to investigate the effect of LHZZ on CRA and explore its pharmacological mechanisms. First, a total of 24 chemical constituents were identified in the 50% aqueous methanol extract of LHZZ granule based on the mass fragment patterns and mass spectral library using the high resolution UPLC-Q-TOF MS/MS system. Subsequently, based on a network pharmacology study, 16 bioactive compounds and 28 targets of the LHZZ associated with CRA were obtained, forming a compound-target network. Molecular docking tests showed tight docking of these compounds with predicted targeted proteins. The protein-protein interaction (PPI) network identified AKT1, CASP3, TP53 and EGFR as hub targets. The Kyoto Encyclopedia of Genes and Genomes pathway network and pathway-target-compound network revealed that the apoptosis pathway was enriched by multiple signaling pathways and multiple targets, including the hub targets. Finally, the reliability of the core targets was evaluated using molecular docking technology and in vitro studies. Our study indicated that the LHZZ particle has preventive and treatment effect on colorectal adenoma through multi-component, multi-target and multi-pathway. 
546 |a EN 
690 |a network pharmacology 
690 |a LHZZ granule 
690 |a colorectal adenoma 
690 |a molecular mechanisms 
690 |a AKT1 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pharmacology, Vol 12 (2021) 
787 0 |n https://www.frontiersin.org/articles/10.3389/fphar.2021.629021/full 
787 0 |n https://doaj.org/toc/1663-9812 
856 4 1 |u https://doaj.org/article/b09aec7a4a5c47e3b138d7c5b79ecf4f  |z Connect to this object online.